Bacterial vaginosis (BV) increases transmission of HIV, enhances the risk of preterm labour, and its associated malodour impacts the quality of life for many women. Clinical diagnosis primarily relies on microscopy to presumptively detect a loss of lactobacilli and acquisition of anaerobes. This diagnostic does not reflect the microbiota composition accurately as lactobacilli can assume different morphotypes, and assigning BV associated morphotypes to specific organisms is challenging. Using an untargeted metabolomics approach we identify novel biomarkers for BV in a cohort of 131 Rwandan women, and demonstrate that metabolic products in the vagina are strongly associated with bacterial diversity. Metabolites associated with high diversity and clinical BV include 2-hydroxyisovalerate and γ-hydroxybutyrate (GHB), but not the anaerobic end-product succinate. Low diversity, and high relative abundance of lactobacilli, is characterized by lactate and amino acids. Biomarkers associated with diversity and BV are independent of pregnancy status, and were validated in a blinded replication cohort from Tanzania (n=45), in which we predicted clinical BV with 91% accuracy. Correlations between the metabolome and microbiota identified Gardnerella vaginalis as a putative producer of GHB, and we demonstrate production by this species in vitro. This work provides a deeper understanding of the relationship between the vaginal microbiota and biomarkers of vaginal health and dysbiosis.
Introduction
The vaginal microbiota is dominated by Lactobacillus species in most women, predominately by L. iners and L. crispatus (1) (2) (3) . When these lactobacilli are displaced by a group of mixed anaerobes, belonging to the genus Gardnerella, Prevotella, Atopobium and others, this increase in bacterial diversity can lead to bacterial vaginosis (BV) (1) (2) (3) .
BV is the most common vaginal condition, affecting an estimated 30% of women at any given time (4) . While many women remain asymptomatic (2) (3) (4) (5) , when signs and symptoms do arise they include an elevated vaginal pH>4.5, discharge, and malodor due to amines (6) (7) (8) . BV is also associated with a number of comorbidities, including increased transmission and acquisition of HIV and other sexually transmitted infections (9) , and increased risk of preterm labour (10) .
In most instances, diagnosis is dependant upon microscopy of vaginal fluid to identify BV-like bacteria alone (Nugent Scoring (11) ), or in combination with clinical signs (Amsel Criteria (12) ). The precision and accuracy of these methods are poor due to the diverse morphology of vaginal bacteria, the observation that many women with BV are asymptomatic, and subjectivity in microscopic examination (13) (14) (15) . Misdiagnosis creates stress for the patient, delays appropriate intervention and places a financial burden on the health care system. A rapid test based on stable, specific biomarkers for BV would improve diagnostic accuracy and speed, and reduce costs through improved patient management. . Metabolomics, defined as the complete set of small molecules in a given environment, has been utilized in a variety of systems to identify biomarkers of disease (16, 17) , and provide functional insight into shifts in microbial communities (18) . Using an untargeted multiplatform metabolomics approach, combined with 16S rRNA gene sequencing, we demonstrate that the vaginal metabolome is driven by bacterial diversity, and identify novel biomarkers of clinical BV that can be reproduced in a blinded validation cohort. We further demonstrate that Gardnerella vaginalis, which has long been thought to be an important contributor to BV is the likely source of one of the most specific compounds.
This work illustrates how changes in community structure alter the chemical composition of the vagina, and identifies highly specific biomarkers for a common condition.
Results

The vaginal metabolome is most correlated with bacterial diversity
We completed a comprehensive untargeted metabolomic analysis of vaginal fluid in two cross-sectional cohorts of Rwandan women: pregnant (P, n=67) and non-pregnant (NP, n=64) ( Table S1 ). To normalize the amount of sample collected, vaginal swabs were weighed prior to and after collection and normalized to equivalent concentrations. This enabled us to collect precise measurements of metabolites in vaginal fluid. Metabolite profiling was carried out using both gas chromatography-mass spectrometry (GC-MS) and liquid chromatography-mass spectrometry (LC-MS), and microbiota composition by 16S rRNA gene sequencing.
The metabolome determined by GC-MS contained 128 metabolites (Table S2) . We conducted a series of partial least squares (PLS) regression analyses to determine the single variable that could best explain the variation in the metabolome. In both cohorts, the diversity of the microbiota, as measured using Shannon's Diversity (19) , was the factor that explained the largest percent variation in the metabolome ( Table S3 ), demonstrating that the vaginal metabolome is most correlated with bacterial diversity (Fig. 1A) . Metabolites robustly associated with this diversity (95% CI <> 0) (Fig. 1B) were determined by jackknifing, and within this group, metabolites associated with extreme diversity tended to have less variation in the jackknife replicates, and were common to both pregnant and non-pregnant women. This identified a core set of metabolites associated with diversity.
The two cohorts overlapped by principal component analysis (PCA) (Fig S1) , and no metabolites were significantly different between pregnant and non-pregnant women (unpaired t-test, Benjamini-Hochberg p > 0.01). Thus, the cohorts were combined for all further analysis.
Metabolites and taxa associated with diversity
A single PLS regression was performed on all samples with Shannon's diversity as a continuous latent variable (Fig S2) . Samples were then ordered by their position on the 1 st component of this PLS. The diversity indices, microbiota and metabolites associated with diversity of PLS ordered samples are shown in Fig. 2 . The vaginal microbiota of Rwandan women were similar to women from other parts of the world, with the most abundant species being L. iners followed by L. crispatus (1) (2) (3) 20) (Fig. 2B , Table S4 ).
Women with high bacterial diversity were dominated by a mixture of anaerobes, including
Gardnerella, Prevotella, Sneathia, Atopobium, Dialister and Megasphaera species. Metabolites associated with high diversity include amines, which contribute to malodor (16) (17) (18) , and a number of organic acid derivatives such as 2-hydroxyisovalerate (2HV), γ-hydroxybutyrate (GHB), 2-hydroxyglutarate and 2-hydroxyisocaproate. Low diversity was characterized by elevated amino acids, including the amine precursors lysine, ornithine and tyrosine. Many of these metabolites were detected by LC-MS, and trimethylamine (high diversity) and lactate (low diversity)
were detected exclusively by this method ( Table S5 ). The identities of metabolites of interest were confirmed with authentic standards when available (Fig. 2, asterisks) . (24) .
Succinate is not associated with diversity or clinical BV
Metabolites associated with diversity are sensitive and specific for clinical BV
We defined clinical BV by the Nugent method, which is the current gold standard for BV diagnosis. This microscopy-based technique defines BV as a score of 7-10 when low numbers of lactobacilli morphotypes are observed, and high numbers of short rods presumed to represent BV associated bacteria are present. Nugent Normal (N) is defined as a score of 1-3, indicating almost exclusively Lactobacillus morphotypes. Intermediate 8 samples are given a score of 4-6 and do not fit into either group. Although Nugent scores correlated well with bacterial diversity in our study, it was apparent from the microbiota and metabolome profiles that two samples (41 and 145) had been misclassified by Nugent ( Fig. 2A, red dots) . The Nugent status of these samples was therefore corrected prior to all further analyses.
In total we identified 49 metabolites that were significantly different between BV and N (unpaired t-test, Benjamini-Hochberg p < 0.01, Benjamini-Hochberg p < 0.01) with OR > 1 are shown in Fig. 3A . Succinate was included as a comparator, although it did not reach significance. Both GHB and 2HV were significantly higher in women with BV, and had OR > 2.0, demonstrating they are novel indicators not only of high bacterial diversity, but also clinical BV. Receiver operating characteristics (ROC) curves built from LC-MS data determined that high 2HV, high GHB, low lactate and low tyrosine were the most sensitive and specific biomarkers for BV, with the largest area under the curve (AUC) achieved using the ratio of 2HV:tyrosine (AUC=0.993) (Fig 3B-D) . ROC curves of GC-MS data identified similar trends, with the largest AUC achieved by the ratio of GHB:tyrosine (AUC=0.968) ( Table S6) .
We determined the optimal cut points for the GHB:tyrosine (0.621) and 2HV:tyrosine (0.882) ratios by selecting values which maximized the sensitivity and specificity for BV. (Fig 4) .
Validation of biomarkers in a blinded replication cohort from Tanzania
We validated these biomarkers in a blinded cohort of 45 pregnant women from Mwanza, Tanzania (Bisanz at al, manuscript submitted). Using the 2HV:tyrosine cut point identified in the Rwanda data set, we identified Nugent BV with 89% sensitivity and 94% specificity in the validation set (AUC=0.946), demonstrating our findings are reproducible in an ethnically distinct population (Fig. 5 , Table S7 ). The GHB:tyrosine ratio cut point was slightly less specific (88%), with an AUC of 0.948. We confirmed that succinate was not significantly different between Nugent N and BV in the validation set, nor was the succinate:lactate ratio.
Identification of G. vaginalis as a producer of GHB
Correlations between metabolites and all taxa indicated that tyramine, putrescine, and cadaverine were most correlated with Dialister (Pearson's R = 0.53, 0.58, 0.69, p < 0.01) ( Table   S9 ). These data suggest that G. vaginalis is the primary source of GHB detected in vivo.
Discussion
We have demonstrated that the vaginal metabolome is strongly correlated with bacterial diversity in both pregnant and non-pregnant Rwandan women, and identified 2HV and GHB as novel biomarkers of clinical BV, the latter of which we attribute to production by G. vaginalis. We obtained extremely accurate results by controlling for the mass of vaginal fluid collected, however we recognize this may not be logistically possible in a clinical setting. To circumvent this need we expressed biomarkers as ratios to the amino acid tyrosine, the most differential amino acid in health. Given the highly conserved nature of the vaginal microbiota across different populations and ethnicities (1) (2) (3) 20) , we expect these biomarkers to be globally applicable for the diagnosis of BV, and our ability to replicate findings in a distinct population strongly supports this theory.
Although G. vaginalis is strongly correlated with GHB in the vagina, it is important to note that no single organism has been identified as the cause of BV, and G. vaginalis is present in many women with a lactobacilli-dominated microbiota. However, as GHB is metabolized from succinate in other bacteria (25, 26) , a similar pathway could exist in G.
vaginalis. Succinate-producing genera may therefore be required, making G. vaginalis essential, but not sufficient for GHB production in the vagina. This remains to be tested.
The finding that succinate, an end product of anaerobic respiration, was not significantly elevated in women with BV was an unexpected outcome. This metabolite has historically been associated with the condition, but has not been tested in the context of a large untargeted metabolomic study. Other groups have reported large ranges in succinate abundance in women with BV (21, 22) , or used pooled samples (22) . This, and our employment of necessary multiple testing corrections, could account for disparities in results. Differences in succinate abundance may have been more pronounced in previous studies if there were a lack of L. crispatus dominated women, which our data indicates is a succinate producer. There is increased expression of succinate producing pathways during BV (27) , and therefore it is probable that large amounts are produced initially, but then rapidly converted to other compounds, such as GHB, by the microbiota and/or host.
In addition to GHB, 2HV was identified as a highly specific novel biomarker for BV. 2HV
is produced from breakdown of branched chain amino acids in humans (28) and some bacteria (29) (30) (31) . When the trend for amino acid depletion in BV is considered, these findings suggest increased amino acid catabolism in this condition. Some of these amino acids are converted to the amines cadaverine, tyramine, and putrescine, which are also associated with BV. These odor-causing compounds were most correlated with Dialister.
Yeoman et al. (32) also linked amines to Dialister species, and the decarboxylating genes required for amine production are expressed by this genus in vivo (27) . These data strongly suggest that Dialister is one of the genera responsible for malodor in the vagina.
Given the small proportion of this genus in women with BV (0.2-8% in our study), this emphasizes the need for functional characterizations of the microbiome using metabolomic and transcriptomic approaches.
The exact role, if any, of GHB and 2HV in the etiology of BV is unknown. Systemically In summary, we have demonstrated using an untargeted, multiplatform approach that differences in the vaginal metabolome are driven by bacterial diversity. Other metabolomic studies have focused on symptom-associated metabolites (31), changes after treatment (36), or longitudinal changes in a few subjects (37) , and included exclusively non-pregnant women. We identified several novel biomarkers for clinical BV that are independent of pregnancy status, and replicated this result in a blinded cohort.
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By combining high-throughput sequencing with advanced mass spectrometry techniques we have shown how in vivo metabolite information can be used to identify sources of metabolic end products in bacterial communities. These techniques can be applied to many systems where organisms may be fastidious or unculturable, and provide a muchneeded link between microbial composition and function.
Methods
Clinical samples
Premenopausal women between the ages of 18 and 55 were recruited at the 
Microbiome profiling
Vaginal swabs for microbiome analysis were extracted using the QIAamp DNA stool Resulting Reads were extracted and de-multiplexed using modifications of in-house
Perl and UNIX-shell scripts with operational taxonomic units (OTUs) clustered at 97%
identity, similar to our reported protocol (38) . Automated taxonomic assignments were carried out by examining best hits from comparison the Ribosomal Database Project (rdp.cme.msu.edu) and manually curated by comparison to the Green genes database (greengenes.lbl.gov) and an in house database of vaginal sequences (Macklaim unpublished) . Taxa with matches at least 95% similarity to query sequences were annotated as such. OTUs were summed to the genus level except for lactobacilli, and rare OTUs found at less than 0.5% abundance in any sample removed. Table S1 displays the nucleotide barcodes and their corresponding samples. Reads were deposited to the Short Read Archive (BioProject ID: xxx). To control for background contaminating sequences, a no-template control was also sequenced. Barplots were constructed with R {r-project.org } using proportional values.
To avoid inappropriate statistical inferences made from compositional data, centred log-ratios (clr), a method previously described by Aitchison (39) and adapted to microbiome data was used with paired t-tests for comparisons of genus and species level data (40) . The Benjamini Hochberg (False Discovery rate) method was used to control for multiple testing with a significance threshold of 0.1. All statistical analysis, unless otherwise indicated, was carried out using R (r-project.org).
Sample Preparation GC-MS
Vaginal swabs were pre-cut into 1. (JNW Scientific). Helium was used as the carrier gas at a constant flow rate of 1 ml/min.
Oven temperature was held at 70 °C for 5 min then increased at a rate of 5 °C/min to 300 °C and held for 10 min. Solvent delay was set to 13 min to avoid solvent and a large lactate peak, and total run time was 61 min. Masses between 25 m/z and 600 m/z were selected by the detector. All samples were run in random order and a standard mix containing metabolites expected in samples was run multiple times throughout to ensure machine consistency.
Data Processing GC-MS
Chromatogram files were de-convoluted and converted to ELU format using the AMDIS Mass Spectrometry software (41) , with the resolution set to high and sensitivity to medium. Chromatograms were then aligned and integrated using Spectconnect (42) (http://spectconnect.mit.edu), with the support threshold set to low. All metabolites found in the blank swab, or believed to have originated from derivatization reagents were removed from analysis at this time. After removal of swab metabolites, the IS matrix from Spectconnect was transformed using the additive log ratio transformation (alr) (39) and ribitol as a normalizing agent (log2(x) / log2(ribitol)). Zeros were replaced with two thirds the minimum detected value on a per metabolite basis prior to transformation. All further metabolite analysis was performed using these alr transformed values.
Metabolites were initially identified by comparison to the NIST 11 standard reference database (http://www.nist.gov/srd/nist1a.cfm). Identities of metabolites of interest were then confirmed by authentic standards if available.
Whole metabolome analysis
In order to visualize trends in the metabolome as detected by GC-MS, principal component analysis (PCA) was performed using pareto scaling. To determine the percentage of variation in the metabolome that could be explained by a single variable we performed a series of partial least squares (PLS) regressions where each variable was used as a continuous latent variable. We tested every taxa, pH, Nugent score, pregnancy status, Shannon's diversity index and sample ID and compared the percent variation explained by the first component of each PLS. The variable with the highest value was determined to be most closely associated with the metabolome (Shannon's Diversity). Analysis was conducted in R using the PLS package and unit variance scaling. Jackknifing with 20% sample removal and 10 000 repetitions was then applied to determine 95% confidence intervals for each metabolite. Metabolites with confidence intervals that did not cross zero in both cohorts (pregnant and non-pregnant) were considered significantly associated with diversity. Heatmaps of significant metabolites were constructed using the heatmap.2 function in R with average linkage hierarchical clustering and manhattan distances. Unless specified otherwise, all tests for differential metabolites between groups were performed using unpaired t-test with a BenjaminiHochberg (False Discovery Rate) significance threshold of p < 0.01 to account for multiple testing and multiple group comparisons. Correlations between metabolites and taxa were performed using alr transformed values for metabolites and clr values with 128
Monte Carlo instances for microbiota data in R using the ALDEx2 package (40) .
Odds ratios of metabolites to identify Nugent BV from Normal were calculated from conditional logistic regressions performed on all metabolites using the glm function in R with 10 000 iterations and a binomial distribution. Metabolites with 95 % CI > 1 and p < 0.01 (unpaired t-test, Benjamini-Hochberg corrected) were determined to be significantly elevated in Nugent BV. "Nugent BV" was defined by the clinical definition of a score of 7-10, with a score of 0-3 being "Nugent Normal". ROC curves and forest plots were built in R using the pROC and Gmisc packages respectively.
Sample Preparation LC-MS
To confirm GC-MS findings, samples which had at least 100 µL remaining after GC- 
Data Processing LC-MS
After data acquisition Thermo .RAW files were converted to .MZML format using Metabolites with corrected p < 0.05 were considered statistically significant. Metabolites detected exclusively by LC-MS that have previously been associated with BV or health (lactate, trimethylamine) were also included in this analysis. Data was log base 10 transformed prior to data analysis and zeros replaced by 2/3 the minimum detected value on a per metabolite basis. To determine optimal cut points of biomarkers for diagnostic purposes, cut points were computed from LC-MS data using the OptimalCutpoints 22 package in R (47) and the Youden Index method (48) .
Validation in blinded replication cohort
Women between the ages of 18 and 40 were recruited from an antenatal clinic at the Nyerere Dispensary in Mwanza, Tanzania as part of a larger study on the effect of micronutrient supplemented probiotic yogurt on pregnancy. The study was approved by both the Medical research Coordinating Committee of the National Institute for Medical
Research (NIMR), as well as from the Health Sciences Research Ethics Board at
Western University. The study was registered with clinicaltrials.gov (NCT02021799).
Samples were collected using the methods mentioned above, and Nugent scores performed by research technicians at NIMR in Mwanza, Tanzania. A subset of samples was selected based on these Nugent scores by a third party, who ensured there was not repeated sampling of any women. Amy McMillan, who performed metabolite analysis, was blinded to the Nugent scores for the duration of sample processing and data analysis. Biomarkers were quantified in samples by LC-MS using the protocols mentioned above. The study was unblinded after the submission of BV status based on the ratio cut points established in the Rwandan data set.
Identification of putative GHB dehydrogenases in G. vaginalis strains
The protein sequence of a bona fide 4-hydroxybutyrate (GHB) dehydrogenase isolated from Clostridium kluyveri (25) (GI:347073) was blasted against all strains of G. vaginalis in the NCBI protein database. Blast results identified multiple isolates containing a putative protein with 44-46% identity to the GHB dehydrogenase from C. kluyveri. The strain used for in vitro experiments (G.vaginalis ATCC 14018) was not present in the NCBI protein database, however a nucleotide sequence in 14018 with 100% nucleotide identity to a putative 4-hydroxybutyrate dehydrogenases in strain ATCC 14019 (GI:311114893) was identified, indicating potential for GHB production by strain 14018.
In vitro extraction of GHB from vaginal isolates
Due to their fastidious nature, we found it difficult to obtain consistent growth of all vaginal strains in liquid media. To circumvent this, a lawn of bacteria was plated and metabolites were extracted from agar punches. All strains were grown on Columbia
Blood Agar (CBA) plates using 5% sheep's blood for 96h under strict anaerobic conditions, with the exception of L. crispatus, which was grown on de Man Rogosa Sharp 
